Skip to content

Quidel finds no issues in investigation into faulty results with coronavirus test

August 20, 2020

Quidel (OTC:QDEL +2.5%) has completed its investigation of a report from a testing location in Vermont of false positives generated by its Sofia SARS Antigen FIA (fluorescent immunoassay) run on the Sofia 2 instrument.

The company says it found no testing site- or product-related problems with either.

It looked into matter after receiving a complaint that certain patients tested positive with its test who later tested negative using a molecular test (PCR).

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: